Karin M. Jorga
Genentech · 63 works · 2,538 citations · h-index 26
Top works
- A Novel Strategy for Physiologically Based Predictions of Human Pharmacokinetics
- Pharmacokinetics of Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Patients with Locally Advanced or Metastatic Solid Tumors: the Role of Alpha-1-Acid Glycoprotein Binding
- Model-Based Prediction of Phase III Overall Survival in Colorectal Cancer on the Basis of Phase II Tumor Dynamics
- Pharmacokinetic‐pharmacodynamic interaction between the COMT inhibitor tolcapone and single‐dose levodopa.
- A Guide to Rational Dosing of Monoclonal Antibodies
- Integrated pharmacokinetics and pharmacodynamics of the novel catechol-O-methyltransferase inhibitor tolcapone during first administration to humans*
- Multiple-dose clinical pharmacology of the catechol- O -methyl-transferase inhibitor tolcapone in elderly subjects
- Saquinavir and ritonavir pharmacokinetics following combined ritonavir and saquinavir (soft gelatin capsules) administration
- A Comprehensive Hepatitis C Viral Kinetic Model Explaining Cure
- Metabolism and excretion of tolcapone, a novel inhibitor of catechol‐O‐methyltransferase
- Predicting sustained virological response and anaemia in chronic hepatitis C patients treated with peginterferon alfa‐2a (40KD) plus ribavirin
- 18 F‐dopa PET evidence that tolcapone acts as a central COMT inhibitor in Parkinson's disease
- A Single Dose Mass Balance Study of the Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Humans Using Accelerator Mass Spectrometry
- Optimizing levodopa pharmacokinetics with multiple tolcapone doses in the elderly*
- The interaction of saquinavir (soft gelatin capsule) with ketoconazole, erythromycin and rifampicin: comparison of the effect in healthy volunteers and in HIV-infected patients
- An Integrated Glucose‐Insulin Model to Describe Oral Glucose Tolerance Test Data in Type 2 Diabetics
- Model-based predictions of expected anti-tumor response and survival in phase III studies based on phase II data of an investigational agent
- Optimal Design for Multivariate Response Pharmacokinetic Models
- Effect of Tolcapone on Plasma Levodopa Concentrations after Coadministration with Levodopa/Carbidopa to Healthy Volunteers
- Pharmacokinetics of ribavirin in patients with hepatitis C virus